Back
Arcturus Therapeutics Holdings 10K Form
Sell
32
ARCT
Arcturus Therapeutics Holdings
Last Price:
18.32
Seasonality Move:
4.49%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-10 | 10Q | ARCT/Arcturus Therapeutics Holdings Quarterly |
| 2020-05-08 | 10Q | ARCT/Arcturus Therapeutics Holdings Quarterly |
| 2020-03-16 | 10K | ARCT/Arcturus Therapeutics Holdings Annual |
| 2019-11-08 | 10Q | ARCT/Arcturus Therapeutics Holdings Quarterly |
| 2019-08-14 | 10Q | ARCT/Arcturus Therapeutics Holdings Quarterly |
Receive ARCT News And Ratings
See the #1 stock for the next 7 days that we like better than ARCT
ARCT Financial Statistics
Sales & Book Value
| Annual Sales: | $157.75M |
|---|---|
| Cash Flow: | $-23.84M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $9.67 |
| Price / Book: | 2.02 |
Profitability
| EPS (TTM): | -2.22000 |
|---|---|
| Net Income (TTM): | $-62.64M |
| Gross Margin: | $0 |
| Return on Equity: | -23.32% |
| Return on Assets: | -15.17% |
Arcturus Therapeutics Holdings Earnings Forecast
Key Arcturus Therapeutics Holdings Financial Ratios
- The Selling, General & Administrative Expenses for ARCT have been equal to 33.52% of Gross Profit Margin.
- The Research & Development expenses have been 121.80% of Revenue.
- The Interest Expense is -2.58% of Operating Income.
- The Net Earning history of ARCT is -18.84% of Total Revenues.
- Per Share Earnings over the last 13 years have been positive in 6 years.
Arcturus Therapeutics Holdings Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ARCT |
| CUSIP: | M1492T |
| Website: | arcturusrx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 4.76 |
| Quick Ratio: | 3.85 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ARCT Technical Analysis vs Fundamental Analysis
Sell
32
Arcturus Therapeutics Holdings (ARCT)
is a Sell
Is Arcturus Therapeutics Holdings a Buy or a Sell?
-
Arcturus Therapeutics Holdings stock is rated a Sell
The current Arcturus Therapeutics Holdings [ARCT] share price is $19.18. The Score for ARCT is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.